European Journal of Cancer with Oral Oncology (Combined Subscription)

European Journal of Cancer
Official Journal of EORTC, ECCO, EACR and EUSOMA

Editor-in-Chief: Alexander M. M. Eggermont
See editorial board for all editorial board information.

The European Journal of Cancer (including EJC Supplements), is an international comprehensive oncology journal that publishes original research, editorial comments, review articles, and news on basic and preclinical research, clinical oncology (medical, pediatric, radiation, surgical), and on cancer epidemiology and prevention.

Official Journal of the European Organisation for Research and Treatment of Cancer (EORTC), the European CanCer Organisation (ECCO), the European Association for Cancer Research (EACR), and the European Society of Breast Cancer Specialists (EUSOMA).

Supplements to the European Journal of Cancer are published under the title EJC Supplements (ISSN 1359-6349). All subscribers to European Journal of Cancer automatically receive this publication.Oral Oncology
A Journal Related to Head and Neck Oncology and Pathology

Oral Oncology now accepts online-only submissions.

Editor: Ezra CohenSee editorial board for all editorial board information.

Official journal of the European Association of Oral Medicine, International Association of Oral Pathologists, and the International Academy of Oral Oncology.

Oral Oncology is an international interdisciplinary journal which draws together for the first time issues relating to the aetiopathogenesis, epidemiology, prevention and management of oral and perioral tumours and of oral disease in patients with malignancies. Papers are invited on the following aspects of cancers arising in the lip, tongue, mouth, salivary glands, pharynx, and the related bones, soft tissues, and lymph glands. (1) Natural history of oral cancer and pre cancer, basic pathology, mestastatic mechanisms. (2) Cellular and molecular markers for diagnosis and prognosis, oncogenes, viruses, growth factors, and adhesion molecules. (3) Epidemiology, risk factors, prevention, screening, and intervention. (4) Advances in imaging and other functional diagnostic modalities. (5) Surgical advances, lasers, photo dynamic therapy, cyro surgery, micro vascular surgery. (6) Multimodality treatment, radiotherapy, chemotherapy, immunotherapy, gene therapy. (7) Advances in reconstruction and rehabilitation, grafts, alloplasty, bone and connective tissue biology, osteoradionecrosis. (8) Teamwork in cancer care, quality of life, nursing, speech and swallowing therapy, nutrition, counselling, pain control, terminal care. (9) Oral effects of tumours at both local and distant sites and their treatment.
Research data may be submitted as a paper, short communication or letter. The journal will consider negative results from well designed studies, which may be published as short communications or letters. Letters may be published as short communications. Letters that comment on an article previously published in the same journal or that express a viewpoint about oncology are also invited. All published papers and short communications, and selected letters containing research data are peer reviewed.

Imprint: Elsevier

Advertisement

advert image